Publications by authors named "Virginia Acha"

Claim this Profile
C
Collaboration for new therapies: maximizing health and innovation.
Jorge Mestre-Ferrandiz, Pierre Meulien, Dennis A Ostwald, Virginia Acha

Front Public Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence to support regulatory submissions: A landscape review and assessment of use cases.
Golnoosh Alipour-Haris, Xinyue Liu, Virginia Acha, Almut G Winterstein, Mehmet Burcu

Clin Transl Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ASAP Framework: A New Tool for Regulatory Agencies to Facilitate Adoption of Pandemic Approaches.
Brenda J Huneycutt, Virginia Acha

Health Secur· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Principles for Good Practice in the Conduct of Non-interventional Studies: The View of Industry Researchers.
Virginia Acha, Bart Barefoot, Ariadna Juarez Garcia, Valerie Lehner, Raffaella Monno

Ther Innov Regul Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future-An Industry View.
Gaia Geraci, Janis Bernat, Céline Rodier, Virginia Acha, Jaqueline Acquah

Ther Innov Regul Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective.
Inkatuuli Heikkinen, Sini Eskola, Virginia Acha, Alan Morrison, Chris Walker

Drug Discov Today· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries.
Kevin Klein, Mümün Gencoglu, Jens Heisterberg, Virginia Acha, Pieter Stolk

BioDrugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?
Kevin Klein, Pieter Stolk, Pär Tellner, Virginia Acha, Sarah Montagne

Ther Innov Regul Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
Jane Moseley, Spiros Vamvakas, Michael Berntgen, Alison Cave, Xavier Kurz, Virginia Acha

Br J Clin Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis